Medical Device Security Testing & VA/PT for IEC 60601 Compliance | Cyber Risk Assessment in Switzerland

IEC 60601 Compliance Services Switzerland

INTRODUCTION :

The rapid digital transformation of medical devices has introduced new cybersecurity challenges that directly impact patient safety, device reliability, and regulatory compliance. Under IEC 60601, cybersecurity is now a critical component of demonstrating the safety and essential performance of medical electrical equipment. In Switzerland’s stringent regulatory environment, manufacturers must show that cybersecurity risks are systematically identified, assessed, and controlled.

Cyberintelsys provides specialized medical device security testing and Vulnerability Assessment & Penetration Testing (VA/PT) aligned with IEC 60601, ISO standards, and CREST-recognized methodologies, helping manufacturers achieve robust cybersecurity readiness and compliance confidence.

Cybersecurity Expectations Under IEC 60601

IEC 60601 focuses on the safety and essential performance of medical electrical equipment. As devices become interconnected and software-driven, cybersecurity threats such as unauthorized access, malware, or denial-of-service can directly compromise safety functions.

Cybersecurity under IEC 60601 is closely linked with:

  • ISO 14971 – Risk management for medical devices

  • IEC TR 60601-4-5 – Cybersecurity guidance for medical electrical equipment

  • IEC 81001-5-1 – Secure product lifecycle processes

  • ISO/IEC 27001 concepts – Information security principles

Cyberintelsys ensures that cybersecurity testing is fully aligned with these frameworks and integrated into the overall safety risk management process.

Why VA/PT Is Critical for Medical Device Compliance

Vulnerability Assessment and Penetration Testing provide objective evidence that security controls are effective and that identified risks are adequately mitigated. For IEC 60601 compliance, VA/PT helps demonstrate that cybersecurity threats do not negatively impact essential performance or introduce unacceptable residual risks.

Key benefits include:

  • Early identification of exploitable vulnerabilities

  • Validation of implemented security controls

  • Reduced risk of non-conformities during conformity assessment

  • Improved confidence for regulators and notified bodies

Cyberintelsys Medical Device Security Testing Approach

1. Medical Device Threat & Attack Surface Analysis

Cyberintelsys begins by identifying:

  • Network interfaces and communication pathways

  • Software, firmware, and operating system components

  • Wireless and remote access points

  • Third-party libraries and supply chain dependencies

This structured analysis ensures all relevant cybersecurity entry points are assessed.

2. Vulnerability Assessment (VA)

The vulnerability assessment phase includes:

  • Configuration and architecture reviews

  • Identification of known and emerging vulnerabilities

  • Secure communication and access control validation

  • Assessment of encryption, authentication, and logging mechanisms

Findings are mapped to ISO 14971 risk criteria to maintain consistency with safety risk management.

3. CREST-Aligned Penetration Testing (PT)

Cyberintelsys performs CREST-aligned penetration testing specifically adapted for medical devices, ensuring:

  • Controlled and safe testing without disrupting essential performance

  • Simulation of real-world attacker techniques

  • Verification of defense effectiveness

  • Clear evidence for regulatory documentation

Testing is performed with patient safety as the highest priority.

4. Risk Evaluation & Mitigation Support

All identified vulnerabilities are:

  • Classified based on severity and exploitability

  • Linked to potential safety impacts

  • Prioritized for remediation

  • Re-tested where required

Cyberintelsys supports manufacturers in defining and validating appropriate risk control measures.

ISO-Aligned Cyber Risk Assessment for Medical Devices

Cyberintelsys aligns security testing outcomes with:

  • ISO 14971 – Risk evaluation and residual risk acceptance

  • ISO/IEC 27001 principles – Information security controls

  • IEC 81001-5-1 – Secure development and maintenance processes

This ensures cybersecurity risks are managed consistently across the entire product lifecycle.

Cybersecurity Documentation for IEC 60601 Readiness

Comprehensive documentation is essential for compliance. Cyberintelsys supports the development of:

  • Cybersecurity Risk Management File inputs

  • VA/PT reports suitable for notified bodies

  • Traceability between threats, risks, and controls

  • Residual risk justifications

  • Evidence supporting IEC 60601 safety claims

This documentation directly supports IEC 60601 test reports, CE marking, and Swiss regulatory submissions.

Why Choose Cyberintelsys in Switzerland

  • Specialized focus on medical device cybersecurity

  • Strong alignment with IEC, ISO, and CREST frameworks

  • Experience supporting Swiss and EU regulatory pathways

  • Practical, regulator-ready testing reports

  • Emphasis on patient safety and essential performance protection

Cyberintelsys helps manufacturers move beyond checklist compliance to achieve measurable cybersecurity assurance.

Conclusion

Medical device security testing and VA/PT are essential components of IEC 60601 compliance in today’s connected healthcare environment. By combining CREST-aligned penetration testing, ISO-based risk management, and deep understanding of medical electrical safety requirements, Cyberintelsys enables manufacturers in Switzerland to confidently demonstrate cybersecurity readiness.

A proactive, standards-driven cybersecurity strategy not only supports successful conformity assessments but also strengthens patient safety, reduces post-market risk, and ensures long-term regulatory trust.

Reach out to our professionals